← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Commercial Officer Christopher Sarchi sold $56K of Replimune Group, Inc.

Sold$56,131
$10.78Price
5,207Shares
−6%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Mon, Nov 18. Filed Wed, Nov 20, 9:30 PM ET, after the close. Not investment advice.